Navigation Links
Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents
Date:6/17/2009

RALEIGH, N.C., June 17 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that it has appointed industry veterans Jon W. McGarity and David Lilley as Executive Vice Presidents. Both gentlemen will work directly with John Campbell, CEO of Campbell Alliance, and the firm's seven practice areas to advise the firm's emerging and midsize client companies. They will focus on enhancing relationships with chief executives in those companies, as well as coordinating Campbell Alliance's resources to help chief executives address highly strategic challenges.

Jon W. McGarity has over 40 years of experience in the pharmaceutical and biotech industry including senior management positions at GlaxoSmithKline, Bristol Myers Squibb, and Novartis (Sandoz Pharmaceuticals). During that time Mr. McGarity has served in various general management, sales, marketing, and managed care roles, having launched over 40 products and completed numerous business development deals.

David Lilley has worked to serve the pharmaceutical and biotech industry for over 30 years while in executive management positions at Johnson & Johnson; Innovex, a contract sales organization; Quintiles Transnational, the world largest global contract research organization (CRO); and NovaQuest, the investment arm of Quintiles.

"In this market environment, executive management teams at emerging and midsize companies are experiencing unprecedented challenges in the areas of clinical development, partnering, financing, and commercialization. Both Jon and David have decades of experience overcoming challenges of this nature and make great additions to the specialized consulting teams already in place at Campbell Alliance," stated John Campbell.

Background Information on Jon W. McGarity

Most recently, Jon W. McGarity was the Pres
'/>"/>

SOURCE Campbell Alliance
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY
2. Campbell Alliance Brand Management Practice to Present at EyeForPharmas Oncology Summit USA and Oncology Market Access Europe Conference
3. Campbell Alliance Hires Joe Dillon, Expands Business Development Practice
4. Campbell Alliance Sales Practice to Present at CBIs Leadership Summit on Evolving the Pharma Sales Model
5. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
6. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
7. Pharmaceutical Institute, in Collaboration With Campbell Alliance, Releases Second Edition of Breakthrough Book on the Inner Workings of the Pharmaceutical Industry
8. Campbell Alliance Clinical Development Practice to Conduct Two Workshops at 44th DIA Annual Meeting
9. Campbell Alliance Trade and Distribution Practice to Speak at CBIs Commercial Contracts and Chargeback Management Conference
10. Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference
11. Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... October 31, 2014 Stronger investment ... construction, finance and consumer electronics will help fuel ... industry research firm IBISWorld has added a report ... growing industry report collection. , The Biometrics Scan ... biometric technologies such as fingerprint, iris, retina and ...
(Date:10/31/2014)... 31, 2014  Atlanta-based Intellimedix could make a ... onset of Ebola by suggesting a new, computational ... Tech,s Center for Computational Systems Biology have spent ... alternative uses for existing drugs through systematic repurposing, ... the bout against Ebola. Logo ...
(Date:10/30/2014)... LONDON , October 30, 2014 ... Organovo Holdings Inc. (NYSE MKT: ONVO), Medivation Inc. (NASDAQ: ... PCYC ), Synthetic Biologics Inc. (NYSE MKT: SYN), and ... five companies can be accessed at: http://investor-edge.com/register ... Composite ended at 4,549.23, down 0.33%, the Dow Jones ...
(Date:10/30/2014)... Global polyvinyl chloride (PVC) demand registered ... during 2008-2009, especially in North America and Europe. However, ... keeping to a growing trend. , The largest chunk ... the construction segment. In 2013, the key PVC application ... and rigid film. Moreover, the PVC was consumed in ...
Breaking Biology Technology:Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 3Atlanta-Based Intellimedix May Help Solve Ebola With Computer Algorithms 2Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 2Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 4Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 5Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 2Global Polyvinyl Chloride Demand Is on Upward Trend Now, Says Merchant Research & Consulting in Its Topical Study 3
... a GPS-enabled asthma inhaler that will help a cutting edge epidemiology ... ... Lodge, MT (PRWEB) April 22, 2009 -- SiliconSky GPS , ... that is has successfully completed the design, development and beta-manufacturing of ...
... April 21 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: ... multiple sclerosis (MS), today announced that the independent ... pivotal phase III MAESTRO-01 Canadian/European trial of dirucotide ... a safety analysis and recommended that the trial ...
... Safety and Tumor Response Data from Dose-Escalation Study ... 100th Annual Meeting 2009 -SOUTH SAN FRANCISCO, Calif. ... (Nasdaq: PARD ), a biopharmaceutical company ... final data from a Phase 1 dose-escalation study ...
Cached Biology Technology:SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program 2SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program 3BioMS Medical's pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board 2Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer 2Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer 3Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer 4Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer 5
(Date:10/31/2014)... letting the air out of a nagging mystery about the ... speculated as to why animal species didn,t flourish sooner, once ... at the end of the Proterozoic period, about 800 million ... that, when most researchers think there also was plenty of ... then, after all. , In a study published Oct. 30 ...
(Date:10/31/2014)... is good for attracting species, but it may not be ... Iowa study has found. , The researchers surveyed two types ... the abundance of two insects that interact with them. They ... cherry and black walnut, they didn,t find a corresponding abundance ... on the walnuts and black cherries and a type of ...
(Date:10/31/2014)... programmed cell death, offering new targets for the treatment ... , The research teams from the Walter and Eliza ... of a key cell death protein called Bak and ... death. Their studies were published in Molecular ... National Academy of Sciences . , Programmed ...
Breaking Biology News(10 mins):Lack of oxygen delayed the rise of animals on Earth 2Green spaces don't ensure biodiversity in urban areas 2A matter of life and death: Cell death proteins key to fighting disease 2
... objects is one of the ultimate challenges in neuroscience. ... of Technology, launched an initiative with the hopes of shedding ... of his "Project Prakash" is to find, treat, and study ... that resulted from this project appears in the December 2006 ...
... shows that more people were at risk of anthrax infection ... office than previously known. The research is published in the ... available online. On the other hand, the study shows, prompt ... against the disease. , In October of 2001, a letter ...
... struggle with the heartache of infertility. Now there is the ... mutation in a gene that causes male infertility in mice. ... that leads specifically to infertility in a mammal has been ... mutations in the DNA of infertile men. , "If you ...
Cached Biology News:Anthrax attack posed greater potential threat than thought 2Researchers find gene mutation that causes infertility in male mice 2
Request Info...
Ultra-sensitive, non-radioactive detection of Protein G. Measure Protein G levels quickly and easily....
Request Info...
TRIS-EDTA based buffer prepared from RNase-free water suitable for storage and dilution of siRNA, pH 8, store at 4 C ...
Biology Products: